— Know what they know.
Not Investment Advice

PVLA NASDAQ

Palvella Therapeutics, Inc.
1W: -2.6% 1M: -11.3% 3M: +35.3% YTD: +15.6% 1Y: +399.0%
$113.99
-1.93 (-1.66%)
 
Weekly Expected Move ±9.3%
$93 $104 $114 $125 $135
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 38 · $1.3B mcap · 7M float · 4.00% daily turnover · Short 61% of daily vol

📊 Key Metrics

TTM
$0M
Revenue
+0.0% YoY
$-49M
Net Income
-306.2% YoY
$-29M
Free Cash Flow
-139.3% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-108.8%
ROA-66.7%
ROIC122.6%

Valuation

P/E-30.3
P/B6.4
EV/EBITDA-46.8

Leverage

Debt/Equity0.02
Current Ratio5.20
Interest Cov.-17.1x

Quality Scores

Piotroski F1/9
Altman Z26.34
Beneish M0.00

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms